Inhibition of growth of hepatocellular carcinoma by co-delivery of anti-PD-1 antibody and sorafenib using biomimetic nano-platelets

Inhibition of growth of hepatocellular carcinoma by co-delivery of anti-PD-1 antibody and sorafenib using biomimetic nano-platelets

Abstract Background Traditional nanodrug delivery systems have some limitations, such as eliciting immune responses and inaccuracy in targeting tumor microenvironments. Materials and methods Targeted drugs (Sorafenib, Sora) nanometers (hollow mesoporous silicon, HMSN) were designed, and then coated...

Full description

Bibliographic Details
Main Authors: Xuanbo Da, Bangping Cao, Jiantao Mo, Yukai Xiang, Hai Hu, Chen Qiu, Cheng Zhang, Beining Lv, Honglei Zhang, Chuanqi He, Yulong Yang
Format: Article
Language:English
Published: BMC 2024-02-01
Series:BMC Cancer
Subjects:
Platelet membrane
Immunotherapy
Sorafenib
Tumor microenvironment
Nanoparticles
Online Access:https://doi.org/10.1186/s12885-024-12006-1

Internet

https://doi.org/10.1186/s12885-024-12006-1

Similar Items